Short Interest in G Medical Innovations Holdings Ltd (NASDAQ:GMVD) Grows By 39.9%

G Medical Innovations Holdings Ltd (NASDAQ:GMVDGet Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 217,400 shares, a growth of 39.9% from the March 31st total of 155,400 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 787,100 shares, the days-to-cover ratio is currently 0.3 days.

A number of large investors have recently modified their holdings of the business. Tradewinds Capital Management LLC lifted its holdings in G Medical Innovations by 143.7% during the first quarter. Tradewinds Capital Management LLC now owns 48,730 shares of the company’s stock valued at $62,000 after purchasing an additional 28,730 shares in the last quarter. Schonfeld Strategic Advisors LLC raised its position in shares of G Medical Innovations by 5.7% during the third quarter. Schonfeld Strategic Advisors LLC now owns 121,600 shares of the company’s stock valued at $272,000 after buying an additional 6,600 shares during the last quarter. Finally, Geode Capital Management LLC bought a new stake in shares of G Medical Innovations during the third quarter valued at approximately $166,000.

NASDAQ:GMVD traded down $0.04 during trading hours on Friday, hitting $1.21. 51,008 shares of the stock traded hands. G Medical Innovations has a 1 year low of $1.15 and a 1 year high of $6.74. The stock has a 50 day moving average price of $1.64 and a 200 day moving average price of $2.31.

About G Medical Innovations (Get Rating)

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days.

See Also

Receive News & Ratings for G Medical Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for G Medical Innovations and related companies with MarketBeat.com's FREE daily email newsletter.